Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Research on Non-Communicable Disease (NCD) Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments.
ID: 343971Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343971
Timeline
    Description

    The National Institutes of Health (NIH) intends to publish a Funding Opportunity Announcement (FOA) for implementation research focused on non-communicable disease (NCD) risk factors among low- and middle-income countries (LMICs) and American Indian/Alaska Native (AI/AN) populations living in urban environments. This initiative aims to solicit applications that propose innovative strategies to reduce the burden of chronic NCDs, such as diabetes and cardiovascular diseases, particularly in city settings where environmental factors contribute to health disparities. The FOA will support research that enhances the adoption and integration of evidence-based health interventions, with applications expected from U.S. and eligible LMIC institutions. Interested applicants should prepare for the anticipated application due dates in Winter/Spring 2023, and can reach out to Brad Newsome, PhD, at brad.newsome@nih.gov or 301-480-8389 for further information.

    Point(s) of Contact
    Brad Newsome, PhD
    (301) 480-8389
    brad.newsome@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America," aimed at supporting innovative research to address health disparities related to non-communicable diseases (NCDs) among Latin American populations and U.S. Hispanics/Latinos. This initiative encourages multidisciplinary research teams to propose clinical trials that focus on community-based and healthcare system interventions for diseases such as obesity, diabetes, cardiovascular conditions, and mental health issues, with a requirement for collaboration that includes at least one principal investigator from Latin America. Applications will be accepted starting January 5, 2024, with a final submission deadline of January 7, 2027, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The funding opportunity reflects a commitment to enhancing healthcare access and quality for underrepresented communities while fostering collaborative research efforts across borders.
    Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Intervention Research to Improve Native American Health," aimed at supporting research initiatives that enhance health outcomes for Native American populations. This initiative encourages the development of culturally appropriate health promotion, disease prevention, and treatment interventions, particularly through planning grants (R34) that may precede clinical trials. The focus is on addressing significant health disparities, including chronic diseases and substance use disorders, by fostering collaborations with Native American communities to ensure the effectiveness and cultural relevance of the interventions. Applicants can request up to $450,000 over three years, with a submission deadline of January 7, 2027. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-285.html.
    Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America," aimed at supporting interdisciplinary research focused on health disparities affecting non-communicable diseases (NCDs) in Latin America and among U.S. Hispanic/Latino populations. The initiative seeks to foster innovative research in clinical epidemiology, healthcare policy evaluation, and health measurement validation, emphasizing collaborations between U.S. and Latin American institutions to address the prevalence and mortality trends of diseases such as diabetes and cardiovascular conditions. Interested applicants, including higher education institutions and nonprofit organizations, must submit their proposals by January 6, 2027, with the application process opening on January 5, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for Environmental Health Disparities Centers (P50)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Environmental Health Disparities Centers (P50) program, aimed at addressing environmental health disparities and promoting environmental justice. This initiative will focus on research and training that targets NIH-designated health disparities populations, particularly racial and ethnic minorities, socioeconomically disadvantaged groups, and individuals from rural or under-resourced areas, in alignment with recent executive orders on environmental justice. The anticipated NOFO is expected to be released in Summer 2024, with applications due in Fall 2024, and the estimated award date is set for July 1, 2025. Interested applicants should prepare to develop responsive applications as further details will be provided in the forthcoming announcement.
    HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research initiatives focused on HIV-associated non-communicable diseases (NCDs) at low- and middle-income country (LMIC) institutions through the R21 Clinical Trial Optional grant. This program aims to support locally relevant research that explores the relationship between HIV infection and the development of NCDs, enhance research capacity, and foster collaborative networks among researchers in LMICs and the U.S. The grant provides funding up to $275,000 over a two-year period, with a submission deadline of December 8, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Intervention Research to Improve Native American Health" (R01 Clinical Trial Optional), aimed at supporting research interventions that enhance health among Native American populations, including Alaska Natives and Native Hawaiians. The initiative seeks to develop, adapt, and test culturally appropriate health promotion and disease prevention interventions, addressing significant health disparities and informed by Indigenous Knowledge. This funding opportunity is critical for promoting health equity and addressing socio-structural determinants affecting Native American communities, with an award ceiling of $500,000 and a project duration of up to five years. Interested applicants can find more information and guidelines at the NIH Grants Information website or contact grantsinfo@nih.gov, with applications due by January 7, 2027.
    Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Intervention Research to Improve Native American Health (R21 Clinical Trials Optional)" aimed at supporting exploratory research to enhance health outcomes in Native American communities. This initiative seeks to fund studies that develop culturally appropriate health strategies, address health disparities, and involve community engagement, particularly emphasizing the importance of Indigenous Knowledge and collaboration with Native American researchers. Grants of up to $275,000 are available for projects lasting up to two years, with applications accepted until January 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-299.html.
    Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)," aimed at supporting studies that address barriers to the adoption and sustainability of evidence-based health interventions, particularly in underserved communities. The initiative encourages research that promotes equitable access to effective practices and explores methods for discontinuing ineffective or harmful interventions, emphasizing the importance of contextual factors and multidisciplinary collaboration. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with a maximum funding amount of $275,000 and a project period of up to two years. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by May 7, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for pilot and exploratory research projects focused on health equity related to tobacco, alcohol, and cannabis use. The initiative aims to investigate disparities in exposure and usage of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. This funding opportunity will utilize the R21 grant mechanism, which supports early-stage research, and is expected to be published in September 2024, with the first application deadline in March 2025. Interested applicants should prepare their proposals in advance, as the estimated award date is December 1, 2025, and further details, including a pre-application webinar, will be announced following the NOFO publication.
    Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for research projects focused on health equity related to tobacco, alcohol, and cannabis policies. This initiative aims to address disparities in exposure and use of these substances by examining new or adapted policies in the U.S., with the goal of advancing equitable health policies. The funding opportunity will utilize the R01 grant mechanism, which is optional for clinical trials, and is expected to open for applications in February 2025, with a funding ceiling of $499,999. Interested applicants should prepare their proposals in advance, as the NOFO is anticipated to be published in September 2024, and further details, including a pre-application webinar, will be announced following the publication.